Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19

Hypercoagulability and thrombosis caused by coronavirus disease 2019 (COVID‐19) are related to the higher mortality rate. Because of limited data on the antiplatelet effect, we aimed to evaluate the impact of aspirin add‐on therapy on the outcome of the patients hospitalized due to severe COVID‐19....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Med Virol
Prif Awduron: Haji Aghajani, Mohammad, Moradi, Omid, Amini, Hossein, Azhdari Tehrani, Hamed, Pourheidar, Elham, Rabiei, Mohammad M., Sistanizad, Mohammad
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2021
Pynciau:
Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242852/
https://ncbi.nlm.nih.gov/pubmed/33913549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.27053
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg